Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546
机构:[1]Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China河北医科大学第四医院[2]Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China临床科室胸心外科(胸外科 心脏血管外科)河北医科大学第四医院[3]Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China临床科室肿瘤内科河北医科大学第四医院[4]Medical Record Room, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China河北医科大学第四医院
The authors would like to point out the following corrections to
Fig. 1A. The authors found that there were numerical writing errors in
Fig. 1A, which appeared at stations 4L, 17 and 20.
第一作者机构:[1]Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, Hebei, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
An Qiuying,Zhang Ping,Wang Hongyan,et al.Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546[J].European Journal Of Surgical Oncology : The Journal Of The European Society Of Surgical Oncology And The British Association Of Surgical Oncology.2025,51(2):109572.doi:10.1016/j.ejso.2024.109572.
APA:
An Qiuying,Zhang Ping,Wang Hongyan,Zhang Zihan,Liu Sihan...&Zhou Zhiguo.(2025).Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546.European Journal Of Surgical Oncology : The Journal Of The European Society Of Surgical Oncology And The British Association Of Surgical Oncology,51,(2)
MLA:
An Qiuying,et al."Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546".European Journal Of Surgical Oncology : The Journal Of The European Society Of Surgical Oncology And The British Association Of Surgical Oncology 51..2(2025):109572